Form 4: Roivant Sciences Director Daniel Gold Reports Significant In-Kind Share Distribution and Ownership Restructuring

Roivant Sciences Ltd. Director and 10% Owner Daniel Allen Gold reported an in-kind distribution of over 36 million common shares from various investment entities for no consideration, alongside an update on his total beneficial ownership including vested restricted stock units.

Summary

• Daniel Allen Gold, a Director and 10% Owner of Roivant Sciences Ltd. (ROIV), filed a Form 4 detailing changes in his beneficial ownership of common shares.
• On June 25, 2025, several entities associated with Mr. Gold, including QVT Roiv Hldgs Onshore Ltd., QVT Roiv Hldgs Offshore Ltd., Fourth Avenue Capital Partners LP, QVT P&E Roiv Hldgs Ltd., QVT Deferred Compensation Holdings Ltd, and QVT Financial Investment Cayman Ltd., made an in-kind distribution of common shares on a pro rata basis for no consideration.
• A total of 36,756,758 common shares were disposed from these entities through the in-kind distribution.
• Following these transactions, Daniel Gold's total beneficial ownership of Roivant Sciences common shares is reported as 40,264,184 shares.
• This total includes 8,956,640 shares held directly and 1,925,909 shares held indirectly through trusts and estate planning vehicles, which were received as part of the distribution and through the vesting of Restricted Stock Units (RSUs).
• The reported beneficial ownership also includes shares indirectly held through QVT P&E Roiv Hldgs Ltd. (1,592,480 shares), QVT Deferred Compensation Holdings Ltd (8,441,428 shares), and QVT Financial Investment Cayman Ltd. (19,347,727 shares).
• Mr. Gold disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• The distribution facilitated the winding down of QVT Roiv Hldgs Offshore Ltd., with one investor's portion contributed to QVT Financial Investment Cayman Ltd., in which QVT FIC has no pecuniary interest in those specific shares.

Sentiment

Score: 5

Explanation: The document is a factual report of insider ownership changes and structural re-organization, with no direct positive or negative implications for the company's operational performance or financial health. It is neutral in sentiment.

Positives

• The report clarifies the ownership structure of a significant insider, Daniel Gold, and the entities through which he holds shares.
• The vesting of Restricted Stock Units (RSUs) on September 12, 2024, and scheduled vesting on September 10, 2025, indicates ongoing compensation and alignment of interests between the director and shareholders.

Negatives

• The in-kind distribution for no consideration represents a re-organization of ownership rather than a direct capital infusion or divestment for value, thus not directly impacting the company's operational financials.

Future Outlook

An annual award of restricted stock units is scheduled to vest 100% on September 10, 2025, subject to the reporting person's continuous service.

Industry Context

This Form 4 filing is a routine disclosure of insider ownership changes, common across all publicly traded companies, and does not reflect broader industry trends or competitive dynamics.

Related Party Transactions

• The in-kind distributions were made by entities (QVT Roiv Hldgs Onshore Ltd., QVT Roiv Hldgs Offshore Ltd., Fourth Avenue Capital Partners LP, QVT P&E Roiv Hldgs Ltd., QVT Deferred Compensation Holdings Ltd, QVT Financial Investment Cayman Ltd.) where Daniel Gold serves as an investment manager, general partner, or director, sharing voting and investment control over the shares.

Stakeholder Impact

• Shareholders: The distribution clarifies the direct and indirect holdings of a significant insider, potentially impacting perceptions of ownership concentration and stability.
• Investment Funds/Partners: Investors in the QVT-related entities received pro rata distributions, affecting their direct holdings of Roivant Sciences shares.

Next Steps

• Vesting of remaining Restricted Stock Units (RSUs) on September 10, 2025, subject to Daniel Gold's continuous service.

Key Dates

Keywords

Roivant Sciences, ROIV, Form 4, Insider Ownership, Beneficial Ownership, Daniel Gold, Equity Distribution, Restricted Stock Units, QVT Financial